bioMerieux (OTCMKTS:BMXMF) Trading 9.7% Higher – Here’s What Happened

bioMerieux (OTCMKTS:BMXMF) shares traded up 9.7% during trading on Monday . The company traded as high as $120.19 and last traded at $120.19. 43 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 175 shares. The stock had previously closed at $109.61.

Wall Street Analyst Weigh In

Separately, BNP Paribas Exane lowered shares of bioMerieux to a “neutral” rating in a research note on Wednesday, January 28th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

bioMerieux Price Performance

The firm’s fifty day moving average price is $120.05 and its two-hundred day moving average price is $127.30. The company has a current ratio of 2.27, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08.

About bioMerieux

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.